Conclusions: Our study provides comprehensive clinical exome profiling, identifies ARHGEF12 mutation as a new driver, and reveals that ITGA6 acts as an early predictive marker in GC with OM. This evidence concerns the gene ARHGEF12 and ocular melanoma.